HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SKB BIO-B

523.500

-3.000-0.57%

Volume:580.33K

Turnover:306.23M

Market Cap:122.07B

PE:-397.81

High:541.500

Open:526.500

Low:518.000

Close:526.500

52wk High:541.500

52wk Low:152.000

Shares:233.19M

HK Float Shares:162.77M

Volume Ratio:0.82

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.316

ROE:-17.56%

ROA:-10.17%

PB:22.27

PE(LYR):-397.81

PS:74.40

Loading ...

Overview Company News Filings

Hong Kong Stock Concept Tracking | MSCI Index Adjustments Take Effect Tomorrow After Market Close! Tech Stocks and Others May Welcome Incremental Funds as Foreign Capital Collectively Turns Bullish on Chinese Assets (With Concept Stocks)

CICCICC Raises SKB BIO-B (06990) Target Price to HK$498.55, Maintains Buy Rating

Stock Track | SKB BIO-B Soars 5.06% as CICC Raises Target Price by 57% on Strong Performance and R&D Progress

CICC Maintains Outperform Industry Rating for SKB BIO-B (06990), Raises Target Price to HK$550

Jefferies Adjusts Sichuan Kelun-Biotech Biopharmaceutical's Price Target to HK$520 from HK$300, Keeps at Buy

MT Newswires Live

Bank of America Securities: Raises SKB BIO-B (06990) Target Price to HK$471.5, Clinical Progress Meets Expectations

CLSA: Raises SKB BIO-B (06990) Target Price to HK$500.6, Reiterates "Outperform" Rating

HK Movers | Biotech Stocks Jump With Transcenta up 9%

Tiger Newspress

Press Release: KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS

SKB BIO-B (06990) Mid-Year Report Review: Commercialization Certainty Drives Growth, Global Innovation Value Reaches New Heights

SKB BIO-B (06990) Reports Interim Results with Revenue of RMB 950 Million and R&D Expenses of RMB 612 Million

Sichuan Kelun-Biotech Biopharmaceutical - Hy Revenue RMB 950.4 Mln

THOMSON REUTERS

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes RMB200 MLN Deposit With Industrial Bank

Windward Bio Launches Global Phase 2 Asthma Trial for SKB378/WIN378 Following Regulatory Approval in Collaboration with Sichuan Kelun-Biotech and Harbour BioMed

Kelun-Biotech's Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of Skb378/Win378

THOMSON REUTERS

Hong Kong Stock Movement | Kelun-Biotech B (06990) Gains Over 3% as UBS Dramatically Upgrades Sac-TMT Sales Forecast

HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%

Tiger Newspress

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Conducted Annual General Meeting

SKB Biopharma Raises HK$1.94 Billion from Share Placement

MT Newswires Live

Sichuan Kelun-Biotech Lung Cancer Combo Gets Breakthrough Tag in China; Shares Slide 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/06990/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":523.5,"timestamp":1757405293005,"preClose":526.5,"halted":0,"volume":580325,"delay":0,"floatShares":162769979,"shares":233185969,"eps":-1.3159620403990842,"marketStatus":"Not Yet Opened","change":-3,"latestTime":"09-09 16:08:13","open":526.5,"high":541.5,"low":518,"amount":306225289,"amplitude":0.044634,"askPrice":523.5,"askSize":900,"bidPrice":520,"bidSize":2400,"shortable":3,"etf":0,"ttmEps":-3.5011840121033693,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":526.5,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"volumeRatio":0.8150510679798115,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-10.17%","roe":"-17.56%","lyrEps":-1.315962,"volumeRatio":0.8150510679798115,"shares":233185969,"dividePrice":0,"high":541.5,"amplitude":0.044634,"preClose":526.5,"low":518,"week52Low":152,"pbRate":"22.27","psRate":"74.40","week52High":541.5,"institutionHeld":0,"latestPrice":523.5,"committee":0.454545,"eps":-1.3159620403990842,"divideRate":0,"volume":580325,"delay":0,"ttmEps":-3.5011840121033693,"open":526.5,"prevYearClose":163.3,"prevWeekClose":524,"prevMonthClose":454.2,"prevQuarterClose":327.2,"fiveDayClose":498.6,"twentyDayClose":403.6,"sixtyDayClose":356.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post Market","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3158,"buy":0.5789,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5789,"analysts":19,"updateTime":1755705600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-09-08","current":-152.440449,"percent":0.362617,"low":-351.800852,"twenty":-215.669071,"median":-80.439464,"eighty":-47.451486,"high":-21.029201,"avg":-125.589374,"sd":85.421153,"marketCap":120328299643},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-08","current":-152.440449,"twenty":-215.669071,"median":-80.439464,"eighty":-47.451486,"marketCap":120328299643}],"updateTime":1757435858293},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197782473","title":"Hong Kong Stock Concept Tracking | MSCI Index Adjustments Take Effect Tomorrow After Market Close! Tech Stocks and Others May Welcome Incremental Funds as Foreign Capital Collectively Turns Bullish on Chinese Assets (With Concept Stocks)","url":"https://stock-news.laohu8.com/highlight/detail?id=1197782473","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197782473?lang=en_us&edition=fundamental","pubTime":"2025-08-25 14:47","pubTimestamp":1756104423,"startTime":"0","endTime":"0","summary":"Global renowned index provider MSCI recently announced its August 2025 index review results. These adjustments will take effect after market close on August 26th. Among MSCI's series of indices,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","BK4585","01530","HSCEI","LU2210149790.SGD","BK1583","BK1615","BK1147","LU0231459107.USD","MSCI","HSTECH","LU0708995401.HKD","LU0109391861.USD","IE00BKPKM429.USD","LU0175139822.USD","LU2210150020.SGD","BK1128","LU0672654240.SGD","LU2265009873.SGD","YANG","BK4614","LU0289961442.SGD","LU0289739343.SGD","LU0196878994.USD","09899","LU1267930730.SGD","BK1593","06990","TTTN","LU0278937759.USD","07226","LU0320765059.SGD","BK1161","IE0009570106.USD","03086","BK4588","LU0289960550.SGD","LU1804176565.USD","LU2095319765.USD","BK4112"],"gpt_icon":1},{"id":"1143149719","title":"CICCICC Raises SKB BIO-B (06990) Target Price to HK$498.55, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1143149719","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143149719?lang=en_us&edition=fundamental","pubTime":"2025-08-22 16:15","pubTimestamp":1755850504,"startTime":"0","endTime":"0","summary":"CICCICC issued a research report expressing continued confidence in the global development of SKB BIO-B's (06990) SKB264, raising the target price from HK$299.93 to HK$498.55 based on discounted cash...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"1127257677","title":"Stock Track | SKB BIO-B Soars 5.06% as CICC Raises Target Price by 57% on Strong Performance and R&D Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1127257677","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127257677?lang=en_us&edition=fundamental","pubTime":"2025-08-21 15:34","pubTimestamp":1755761690,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) saw its stock price surge 5.06% during Thursday's trading session, following a bullish report from CICC. The investment bank maintained its \"outperform industry\" rating for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06990"],"gpt_icon":0},{"id":"1180908402","title":"CICC Maintains Outperform Industry Rating for SKB BIO-B (06990), Raises Target Price to HK$550","url":"https://stock-news.laohu8.com/highlight/detail?id=1180908402","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180908402?lang=en_us&edition=fundamental","pubTime":"2025-08-21 11:58","pubTimestamp":1755748706,"startTime":"0","endTime":"0","summary":"CICC released a research report stating that due to SKB BIO-B's (06990) strong licensing revenue recognition and effective cost management, the firm maintains its outperform industry rating....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2560417132","title":"Jefferies Adjusts Sichuan Kelun-Biotech Biopharmaceutical's Price Target to HK$520 from HK$300, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2560417132","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560417132?lang=en_us&edition=fundamental","pubTime":"2025-08-20 17:55","pubTimestamp":1755683729,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co (HKG:6990) has an average rating of buy and mean price target of HK$480.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990"],"gpt_icon":0},{"id":"1153957967","title":"Bank of America Securities: Raises SKB BIO-B (06990) Target Price to HK$471.5, Clinical Progress Meets Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1153957967","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153957967?lang=en_us&edition=fundamental","pubTime":"2025-08-20 17:20","pubTimestamp":1755681632,"startTime":"0","endTime":"0","summary":"Bank of America Securities released a research report stating that SKB BIO-B's (06990) core asset SKB264 has achieved steady progress across multiple indications. The firm has increased the success...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1130180331","title":"CLSA: Raises SKB BIO-B (06990) Target Price to HK$500.6, Reiterates \"Outperform\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1130180331","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130180331?lang=en_us&edition=fundamental","pubTime":"2025-08-19 10:36","pubTimestamp":1755570980,"startTime":"0","endTime":"0","summary":"CLSA released a research report stating that it has adjusted its valuation based on the latest data. Using a discounted cash flow (DCF) approach, the firm raised its target price for SKB BIO-B...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"1105286865","title":"HK Movers | Biotech Stocks Jump With Transcenta up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105286865","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105286865?lang=en_us&edition=fundamental","pubTime":"2025-08-19 10:01","pubTimestamp":1755568884,"startTime":"0","endTime":"0","summary":"On August 19 (Tuesday), Hong Kong biotech stocks were active in early trading. Transcenta rose 9%, LaiKang Medicine rose 6%, Venus Medtech rose 4%, Kelun-Biotech Biopharmaceutical rose 3%, Luzhu Biotechnology rose 2%, ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3c69330474cfca501aba698b1d21b7cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500","02480","06628","06990","02105"],"gpt_icon":0},{"id":"2560906646","title":"Press Release: KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2560906646","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560906646?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:22","pubTimestamp":1755512520,"startTime":"0","endTime":"0","summary":"-- Revenue reached approximately RMB950.4 million, with total commercial. sales RMB309.8million, representing a significant increase in proportion. -- Research and development expenses was approximately RMB611.5 million. -- Loss for the period was RMB145.2 million; adjusted loss for the period[1]. -- Cash and cash equivalents[2] amounted to approximately RMB4527.8 million,assets measured at fair value through profit or loss, financial assets. measured at amortized cost and financial assets measured at fair value through. CHENGDU, China, Aug. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Pharmaceutical Co., Ltd.  announced its unaudited interim results for the six months ended 30 June 2025 .The first TROP2 ADC drug approved for marketing in LC globally.TNBC: Approved by the National Medical Products Administration  for the treatment of adult patients with unresectable locally advanced or metastatic TNBC who have received at least two prior systemic therapies. The Company has initiated ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","R","CRC","BC","BK4232","BK4022","LU0196878994.USD","LU0266512127.USD","BK4190","LU0456854461.SGD","06990","BK4213"],"gpt_icon":0},{"id":"1164402293","title":"SKB BIO-B (06990) Mid-Year Report Review: Commercialization Certainty Drives Growth, Global Innovation Value Reaches New Heights","url":"https://stock-news.laohu8.com/highlight/detail?id=1164402293","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164402293?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:21","pubTimestamp":1755512479,"startTime":"0","endTime":"0","summary":"Since the beginning of this year, Hong Kong's innovative pharmaceutical sector has continued its \"comeback\" performance. Wind data shows that southbound capital net inflows into the pharmaceutical...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"1110935820","title":"SKB BIO-B (06990) Reports Interim Results with Revenue of RMB 950 Million and R&D Expenses of RMB 612 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1110935820","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110935820?lang=en_us&edition=fundamental","pubTime":"2025-08-18 17:16","pubTimestamp":1755508584,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of RMB 950 million, representing a year-on-year decrease of 31.3%. R&D expenses...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2560970460","title":"Sichuan Kelun-Biotech Biopharmaceutical -  Hy Revenue RMB 950.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2560970460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560970460?lang=en_us&edition=fundamental","pubTime":"2025-08-18 16:58","pubTimestamp":1755507490,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3U8079:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2554795681","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes RMB200 MLN Deposit With Industrial Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2554795681","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554795681?lang=en_us&edition=fundamental","pubTime":"2025-07-25 23:04","pubTimestamp":1753455896,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes RMB200 MLN Deposit With Industrial BankJuly 25 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SUBSCRIBES RMB200 MILLION DEPOSIT WITH INDUSTRIAL BANKFurther company coverage: 6990.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nFWN3TM0J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2553277243","title":"Windward Bio Launches Global Phase 2 Asthma Trial for SKB378/WIN378 Following Regulatory Approval in Collaboration with Sichuan Kelun-Biotech and Harbour BioMed","url":"https://stock-news.laohu8.com/highlight/detail?id=2553277243","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553277243?lang=en_us&edition=fundamental","pubTime":"2025-07-23 21:25","pubTimestamp":1753277119,"startTime":"0","endTime":"0","summary":"Windward Bio Launches Global Phase 2 Asthma Trial for SKB378/WIN378 Following Regulatory Approval in Collaboration with Sichuan Kelun-Biotech and Harbour BioMed. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via PR Newswire  on July 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL6RBkf2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU1064130708.USD","LU1934453819.USD","06990","LU1979443071.USD","LU2148510915.USD","LU0196878994.USD","BK1161","BK0060","002422","BK0239"],"gpt_icon":0},{"id":"2553432322","title":"Kelun-Biotech's Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of Skb378/Win378","url":"https://stock-news.laohu8.com/highlight/detail?id=2553432322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553432322?lang=en_us&edition=fundamental","pubTime":"2025-07-23 21:25","pubTimestamp":1753277100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nTUA4STNYW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"1143103552","title":"Hong Kong Stock Movement | Kelun-Biotech B (06990) Gains Over 3% as UBS Dramatically Upgrades Sac-TMT Sales Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=1143103552","media":"Market Watcher","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143103552?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:20","pubTimestamp":1752585636,"startTime":"0","endTime":"0","summary":"Shares of Kelun-Biotech B (06990.HK) climbed beyond 3% during trading, settling at a 2.28% rise to HK$350.60 by press time. Trading volume reached HK$116 million. UBS research indicates the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"1109523465","title":"HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109523465","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109523465?lang=en_us&edition=fundamental","pubTime":"2025-07-03 11:00","pubTimestamp":1751511647,"startTime":"0","endTime":"0","summary":"HK Innovative Drug Concept Stocks Rose. Biostar up 15%; Akeso up 11%; SKB Bio and Innovent Bio up more than 7%; Zai Lab up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8f9423fb69201ea469acc4a9341fc19e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","06978","09688","09926","06606","03347","01801","02137","03759","02269","09966","01672","06990","02359","09606","09995","02563"],"gpt_icon":0},{"id":"2544175132","title":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544175132","media":"Reuters","labels":["executive","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544175132?lang=en_us&edition=fundamental","pubTime":"2025-06-20 22:42","pubTimestamp":1750430576,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. held its Annual General Meeting on June 20, 2025. During the meeting, several proposals were considered. The financial budget report for the year 2025 was approved. The report of the Board of Directors for the year 2024 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief on June 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL7M79yS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148510915.USD","BK1161","002422","BK0060","LU1064131003.USD","06990","LU1979443071.USD","LU0196878994.USD","LU1934453819.USD","BK0239","LU1064130708.USD"],"gpt_icon":0},{"id":"2542977835","title":"SKB Biopharma Raises HK$1.94 Billion from Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2542977835","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542977835?lang=en_us&edition=fundamental","pubTime":"2025-06-12 17:53","pubTimestamp":1749721997,"startTime":"0","endTime":"0","summary":"Drug company Sichuan Kelun-Biotech Biopharmaceutical  completed the placing of 5,918,000 shares to at least six investors at HK$331.8 apiece to raise net proceeds of a little over HK$1.94 billion, a Thursday Hong Kong bourse filing said.Proceeds will be used for the R&D, trials, registration, manufacturing, and commercialization of products; external collaborations; product pipeline portfolio expansion; and replenishment of working capital among other uses.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2542711379","title":"Sichuan Kelun-Biotech Lung Cancer Combo Gets Breakthrough Tag in China; Shares Slide 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542711379","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542711379?lang=en_us&edition=fundamental","pubTime":"2025-06-11 13:07","pubTimestamp":1749618436,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  said its sacituzumab tirumotecan  in combination with tagitanlimab has received a breakthrough therapy designation in China for lung cancer, according to a Wednesday Hong Kong bourse filing.The designation, granted by China's National Medical Products Administration , covers first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer in patients without actionable genomic alterations.Kelun-Biotech said this marks the fifth breakthrough tag for sac-TMT granted by the NMPA.Sac-TMT is already approved in China for multiple indications and is being developed globally with Germany's Merck, which is leading 14 Phase 3 trials outside Greater China, the filing said.Shares of the biopharmaceutical firm were down about 3% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}